MAGE-10.A2
Term · Oncology and biomedicine · MLC-T-ONC-014962
A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-014962 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014962",
"term": "MAGE-10.A2",
"field": "Oncology and biomedicine",
"definition": "A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mage-10-a2/"
}
Record 10,525 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.